Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
3
Neutral
6
Bullish
5
Bearish
28
Neutral
6
Bullish
12
Bearish
25
Neutral
0
Bullish
7
Discovery themes featuring this stock
Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life.
The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi.
Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments.
The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery.
A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.
Healthcare Services
Hospital
3,677 Cr
High Risk
21.5
56.3
2.2
5.6
640.05
342.35
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Indraprastha Medical Corporation Ltd (INDRAMEDCO) is currently trading at 406.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life. The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi. Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments. The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery. A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.
Over the past 52 weeks, Indraprastha Medical Corporation Ltd has traded between a low of ₹342.35 and a high of ₹640.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Indraprastha Medical Corporation Ltd has a market capitalization of approximately 3,677.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Indraprastha Medical Corporation Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.45 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 3,677.00 Cr, Indraprastha Medical Corporation Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Indraprastha Medical Corporation Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Indraprastha Medical Corporation Ltd is 21.45. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
5180.55 | 6,173 Cr | 97.76 | 5.19 | 0.18 | 19.21 | 21.31 | 12.30 | ||
235.30 | 3,704 Cr | 42.61 | 3.24 | 0.17 | 10.76 | 13.34 | 6.76 | ||
428.00 | 3,677 Cr | 21.45 | 5.59 | 1.12 | 26.54 | 34.84 | 19.17 | ||
4770.00 | 2,347 Cr | 32.76 | 7.46 | 0.12 | 20.02 | 14.77 | 9.58 | ||
161.25 | 1,746 Cr | 424.34 | 1.74 | 0.00 | 0.45 | 6.06 | 0.23 | ||
90.39 | 1,464 Cr | 40.53 | 8.03 | 0.00 | 16.69 | 19.54 | 12.23 | ||
137.65 | 1,060 Cr | 26.37 | 5.35 | 2.71 | 26.36 | 23.95 | 0.00 | ||
| Median: 7 Co. | — | 235.30 | 2,347 Cr | 40.53 | 5.35 | 0.17 | 19.21 | 19.54 | 9.58 |
